Correlation Between Visa and Elicio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Elicio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Elicio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Elicio Therapeutics, you can compare the effects of market volatilities on Visa and Elicio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Elicio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Elicio Therapeutics.

Diversification Opportunities for Visa and Elicio Therapeutics

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Visa and Elicio is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Elicio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicio Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Elicio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicio Therapeutics has no effect on the direction of Visa i.e., Visa and Elicio Therapeutics go up and down completely randomly.

Pair Corralation between Visa and Elicio Therapeutics

Taking into account the 90-day investment horizon Visa is expected to generate 1.41 times less return on investment than Elicio Therapeutics. But when comparing it to its historical volatility, Visa Class A is 3.01 times less risky than Elicio Therapeutics. It trades about 0.29 of its potential returns per unit of risk. Elicio Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  460.00  in Elicio Therapeutics on August 24, 2024 and sell it today you would earn a total of  52.00  from holding Elicio Therapeutics or generate 11.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Visa Class A  vs.  Elicio Therapeutics

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Elicio Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Visa and Elicio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Elicio Therapeutics

The main advantage of trading using opposite Visa and Elicio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Elicio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicio Therapeutics will offset losses from the drop in Elicio Therapeutics' long position.
The idea behind Visa Class A and Elicio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios